NSRX vs MDCX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 14, 2026

NSRX

41.9
AI Score
VS
MDCX Wins

MDCX

42.8
AI Score

Investment Advisor Scores

NSRX

42score
Recommendation
HOLD

MDCX

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NSRX MDCX Winner
Net Income -5.86M -20.66M NSRX
Operating Income -4.90M -20.08M NSRX
ROE -211.6% 1171.4% MDCX
ROA -117.0% -76.2% MDCX
Total Assets 5.00M 27.12M MDCX
Cash 1.24M 15.17M MDCX
Current Ratio 2.24 1.57 NSRX

Relative Price Performance (Last 90 Days)

NSRX 1M: +14.1% · 3M: +26.7% MDCX 1M: -55.0% · 3M: -52.8%

Current Technical Phase

NSRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 50

RSI (14): 50.2 · Price: $3.65

MDCX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -17.7%), weak momentum, RSI 27

RSI (14): 26.5 · Price: $0.16

Fundamentals Snapshot

Metric NSRX MDCX
Market Cap
Forward P/E -3.2 -0.5
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -1.13 -2.36
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MDCX is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.